FDX1 and colon adenocarcinoma: We verified the level of CD4+ T cells and CD8+ T cells immune infiltration in 6 COAD patients with high expression of FDX1 by flow cytometry, and the results were completely consistent with the analysis of TIMER database, which effectively explained the good prognosis of patients with high expression of FDX1.